炔雌醇环丙孕酮片联合胰岛素增敏剂在多囊卵巢综合征促排卵中的应用效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (608 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the ovulation induction after the treatment of polycystic ovary syndrome with Eynestradiol Cyproterone Tablets combined with Insulin Sensitizer. Methods A total of 100 cases of polycystic ovary syndrome patients admitted to the Department of Obstetrics and Gynecology of Beijing Normal University Hospital from December 2018 to December 2019 were selected as research objects, according to random number table method, they were divided into control group (received Ethinylestradiol Cyproterone Tablets therapy) and study group (combined with Insulin Sensitizer on the basis of control group), with 50 cases in each group. Body mass index (BMI), waist-hip ratio(WHR), body weight, endometrial development, incidence of dominant follicles, incidence of ovarian hyperstimulation syndrome and pregnancy rate were compared between the two groups before and after treatment. Results Before treatment, there were no significant differences in BMI, WHR and body weight between the two groups (P>0.05). After treatment, the BMI, WHR and body weight of two groups were lower than those before treatment, and the BMI, WHR and body weight in the study group were lower than those in the control group, the differences were statistically significant(P<0.05). The endometrial development, incidence of dominant follicles and pregnancy rate in the study group were higher than those in the control group, and the incidence of ovarian hyperstimulation syndrome in the study group was lower than that in the control group, the differences were statistically significant (P<0.05). Conclusion For the treatment of polycystic ovary syndrome, the combination of Eynestradiol Cyproterone Tablets and Insulin Sensitizer can adjust the patients′ menstrual cycle, improve endocrine and metabolic disorders, the ovulation rate and pregnancy rate,which is worthy of clinical promotion and application.

Key words： Polycystic ovary syndrome Ethinylestradiol Cyproterone Tablets Insulin Sensitizer Ovulation induction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAO Yan
	LI Chenxia

Cite this article:

ZHAO Yan,LI Chenxia. Application effect of Ethinylestradiol Cyproterone Tablets combined with Insulin Sensitizer on ovulation induction in polycystic ovary syndrome[J]. 中国当代医药, 2022, 29(27): 108-110.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I27/108

[1]	刘颖.多囊卵巢综合征应用胰岛素增敏剂联合达英-35治疗效果分析[J].中国现代药物应用，2020，14（22）：179-181.
[2]	徐鑫鑫.达英-35 与胰岛素增敏剂治疗多囊卵巢综合征的效果观察[J].中国现代药物应用，2020，14（17）：192-194.
[3]	苏雅琴.达英-35 联合胰岛素增敏剂治疗多囊卵巢综合征疗效研究[J].河北医药，2020，42（13）：2039-2042.
[4]	杨惠贞.达英-35 联合胰岛素增敏剂治疗多囊卵巢综合征的疗效[J].实用中西医结合临床，2020，20（1）：151-152.
[5]	李琴，雷勇.达英-35 配合胰岛素增敏剂治疗对多囊卵巢综合征患者卵巢功能、血清空腹胰岛素、瘦素及性激素水平的影响[J].中国妇幼保健，2019，34（18）：4277-4279.
[6]	刘晓梅，邢燕，李景丽，等.胰岛素增敏剂联合达英-35 治疗多囊卵巢综合征疗效观察[J].实用妇科内分泌电子杂志，2019，6（8）：87，90.
[7]	丁立娟.胰岛素增敏剂治疗多囊卵巢综合征内分泌紊乱患者的效果观察[J].实用妇科内分泌杂志，2017，4（15）：59-60.
[8]	钱方圆.达英-35 与胰岛素增敏剂治疗多囊卵巢综合征后促排卵药物的临床体会[J].临床医药文献电子杂志，2017，4（22）：4311，4314.
[9]	徐春，胡晓丹.多囊卵巢综合征合并胰岛素抵抗患者应用两种不同胰岛素增敏剂对糖代谢的影响[J].当代医学，2022，28（4）：76-78.
[10]	谢莉，王娟，赵井苓，等.丹栀逍遥散结合炔雌醇环丙孕酮治疗女大学生多囊卵巢综合征的效果[J].中国医药科学，2022，12（8）：92-95，117.
[11]	钟沛文，关宝星，张四友，等.二甲双胍联合炔雌醇环丙孕酮片治疗多囊卵巢综合征疗效及对患者性激素和IP-10、HSP90 水平的影响[J].中国妇产科临床杂志，2021，22（3）：276-278.
[12]	杜晓静，耿慧英，毛丽梅，等.益精补肾方结合二甲双胍及炔雌醇环丙孕酮片治疗多囊卵巢综合征的临床效果分析[J].中国医院药学杂志，2021，41（1）：37-41.
[13]	陈德军，徐一玲，廉红梅，等.二甲双胍联合炔雌醇环丙孕酮片对多囊卵巢综合征患者糖链抗原125 及胰岛素抵抗的影响[J].中国临床药理学杂志，2020，36（18）：2772-2774.
[14]	郑克琼.炔雌醇环丙孕酮联合二甲双胍治疗多囊卵巢综合征的疗效及对性激素和胰岛素水平的影响[J].中国药物与临床，2020，20（8）：1293-1295.
[15]	尹璐，闫晓颖，郎宇.二甲双胍联合炔雌醇环丙孕酮片治疗多囊卵巢综合征的疗效观察[J].药学服务与研究，2019，19（4）：318-320.
[16]	王立霞，李燕，王晓倩，等.探讨二甲双胍与炔雌醇环丙孕酮片治疗多囊卵巢综合征的疗效及其对性激素、血糖的影响[J].中国性科学，2019，28（2）：69-72.